Rystiggo (firdapse) can cause high blood pressure as a side effect [1]. This adverse event is a concern for patients and healthcare providers managing treatment with this medication.
What is Rystiggo used for?
Rystiggo is approved to treat Lambert-Eaton myasthenic syndrome (LEMS) in adults [1]. LEMS is a rare autoimmune disorder that affects the neuromuscular junction, leading to muscle weakness [2].
What are the common side effects of Rystiggo?
Besides high blood pressure, other common side effects of Rystiggo include upper respiratory tract infections, nasopharyngitis (common cold symptoms), and pyrexia (fever) [1].
How is high blood pressure managed during Rystiggo treatment?
Patients taking Rystiggo are typically monitored for blood pressure changes. If high blood pressure occurs or worsens, healthcare providers may adjust the dosage of Rystiggo or prescribe antihypertensive medications to manage it [1].
What are the risks associated with Rystiggo?
The risks associated with Rystiggo include the potential for increased blood pressure, which can be serious if not managed. Other risks are related to the side effects mentioned previously [1].
Where can I find more information on Rystiggo and its patents?
Information on Rystiggo, including its patent status and potential generic competition, can be found on DrugPatentWatch.com [3]. DrugPatentWatch.com provides data on drug patents, exclusivity, and market exclusivity expiry dates [3].
Sources
1. https://www.drugpatentwatch.com/p/rystiggo
2. https://www.ninds.nih.gov/health-information/disorders/lambert-eaton-myasthenic-syndrome
3. https://www.drugpatentwatch.com/